ArticleMedicine2026

Novel oral chidamide and valganciclovir regimen for EBV-PTLD post-hematopoietic stem cell transplantation: A case report.

Yaogong Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.